NVO
Novo-Nordisk A/SstockNYSEADR
At CloseNov 18, 2026 3:59:59 PM EST
39.44USD-3.084%(-1.26)16,117,786
Pre-marketNov 18, 2026 9:29:30 AM EST
40.21USD-1.204%(-0.49)
After-hoursNov 18, 2026 4:55:30 PM EST
39.41USD-0.085%(-0.03)
Loading…
Loading…
173.87B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$40.70
Beta
0.95
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$39.90
SMA 200
$43.00
Avg. Vol 10D
14.57M
Avg. Vol 30D
11.68M
Avg. Vol 90D
12.45M
Relative Vol
1.13
4.41B
3.16B
71.60%
38,286,865
1.21%
4.04
55%/45%
33.37%
20.24%
0.2800%
10,000,000
12
19,458
121,034
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Nov 18, 2026
Anthropic IPO: Live Updates and Commentary ·
Kiplinger
Nov 17, 2026
Eli Lilly vs. Novo Nordisk: Which GLP-1 Stock Is a Better Buy for 2027? ·
The Motley Fool+1 source
Why Is Omeros Stock Trading Lower Tuesday? ·
Benzinga
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 41.09 | 2026-11-11 | -3.99% | 0.630 |
| 1M | 38.42 | 2026-10-19 | +2.68% | 0.807 |
| 3M | 45.71 | 2026-08-18 | -13.70% | 0.631 |
| 6M | 44.28 | 2026-05-18 | -10.91% | 0.218 |
| 1Y | 47.55 | 2025-11-18 | -17.04% | 0.948 |
| 2Y | 99.81 | 2024-11-18 | -60.48% | — |
| 5Y | 57.52 | 2021-11-18 | -31.41% | 0.672 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $39.45, and today's volume is 13,170,221. NVO is down 3.071% today. The 30 day average volume is 11.68M. NVO market cap is $173.87B with 4.41B shares outstanding.
